• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday

    4/17/24 10:55:18 AM ET
    $AAOI
    $AIRS
    $ALXO
    $AMC
    Semiconductors
    Technology
    Medical/Nursing Services
    Health Care
    Get the next $AAOI alert in real time by email

    U.S. stocks were lower, with the Dow Jones index falling over 50 points on Wednesday.

    Shares of United Airlines Holdings, Inc. (NASDAQ:UAL) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter financial results.

    Revenue of $12.539 billion topped estimates of $12.4 billion. The company posted a loss of 15 cents per share, versus expectations for a loss of 57 cents per share, according to data from Benzinga Pro.

    United Airlines shares jumped 11.2% to $46.12 on Wednesday.

    Here are some other big stocks recording losses in today’s session.

    • Edible Garden AG Incorporated (NASDAQ:EDBL) surged 112% to $9.73 after the company reported preliminary first quarter FY24 results.
    • The Children's Place, Inc. (NASDAQ:PLCE) shares jumped 35.5% to $9.64 after the company announced it entered into a new financing agreement with Mithaq Capital.
    • Cullinan Therapeutics, Inc. (NASDAQ:CGEM) rose 14% to $19.75. HC Wainwright & Co. analyst Edward White maintained Cullinan Oncology with a Buy and lowered the price target from $34 to $29.
    • Trump Media & Technology Group Corp. (NASDAQ:DJT) rose 11% to $25.35.
    • ALX Oncology Holdings Inc. (NASDAQ:ALXO) climbed 10.4% to $16.01.
    • Mesoblast Limited (NASDAQ:MESO) rose 8.5% to $5.09.
    • Applied Optoelectronics, Inc. (NASDAQ:AAOI) jumped 8.4% to $13.00.
    • AMC Entertainment Holdings, Inc. (NYSE:AMC) surged 7.5% to $2.9250, bouncing back from the selling pressure the stock has faced in recent week.
    • AirSculpt Technologies, Inc. (NASDAQ:AIRS) rose 7.2% to $5.63.
    • Zuora, Inc. (NYSE:ZUO) rose 6.4% to $9.01.
    • Interactive Brokers Group, Inc. (NASDAQ:IBKR) gained 5.2% to $112.93 following upbeat quarterly earnings.

     

    Now Read This: Discover Financial Gears Up For Q1 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

    Get the next $AAOI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAOI
    $AIRS
    $ALXO
    $AMC

    CompanyDatePrice TargetRatingAnalyst
    Interactive Brokers Group Inc.
    $IBKR
    4/8/2026$75.00Mkt Perform
    Keefe Bruyette
    ALX Oncology Holdings Inc.
    $ALXO
    3/19/2026$5.00Overweight
    Wells Fargo
    ALX Oncology Holdings Inc.
    $ALXO
    3/6/2026$6.00Buy
    UBS
    Applied Optoelectronics Inc.
    $AAOI
    2/27/2026$55.00Outperform → Market Perform
    Northland Capital
    Applied Optoelectronics Inc.
    $AAOI
    2/27/2026$54.00Sell → Neutral
    B. Riley Securities
    Cullinan Therapeutics Inc.
    $CGEM
    2/17/2026$33.00Buy
    Citigroup
    Cullinan Therapeutics Inc.
    $CGEM
    2/2/2026$30.00Buy
    Guggenheim
    United Airlines Holdings Inc.
    $UAL
    12/18/2025$145.00Overweight
    Wells Fargo
    More analyst ratings

    $AAOI
    $AIRS
    $ALXO
    $AMC
    SEC Filings

    View All

    SEC Form DEF 14A filed by AirSculpt Technologies Inc.

    DEF 14A - Airsculpt Technologies, Inc. (0001870940) (Filer)

    4/15/26 4:05:50 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    SEC Form 6-K filed by Mesoblast Limited

    6-K - MESOBLAST LTD (0001345099) (Filer)

    4/15/26 9:10:26 AM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form PRE 14A filed by Applied Optoelectronics Inc.

    PRE 14A - APPLIED OPTOELECTRONICS, INC. (0001158114) (Filer)

    4/14/26 5:16:16 PM ET
    $AAOI
    Semiconductors
    Technology

    $AAOI
    $AIRS
    $ALXO
    $AMC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Applied Optoelectronics Announces Date of First Quarter 2026 Financial Results Conference Call

    SUGAR LAND, Texas, April 16, 2026 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (NASDAQ:AAOI) ("AOI"), a leading provider of advanced optical and HFC networking products that power AI, today announced that it will release financial results for its first quarter ended March 31, 2026, on Thursday, May 7, 2026. AOI will host a conference call and webcast for analysts and investors to discuss its first quarter 2026 financial results and outlook for its second quarter 2026 at 4:30 p.m. Eastern Time / 3:30 p.m. Central Time the same day. To participate in the call, please dial 844-890-1794 and ask to be joined to the AOI call. A live audio webcast of the conference call and supplemental fi

    4/16/26 4:10:00 PM ET
    $AAOI
    Semiconductors
    Technology

    Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products

    NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has acquired an exclusive worldwide license to a patented chimeric antigen receptor (CAR) technology platform for precision-enhanced augmentation of therapeutic mesenchymal lineage stromal cell (MSC) products. Mesoblast plans to incorporate the engineered CARs to further boost effectiveness of Mesoblast's products, with the goal of enhancing the target specificity and augmenting inherent properties of immunomodulation and tissue regeneration. Mesoblast's MSC technology platforms, including the first and on

    4/14/26 8:10:56 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer

    - Veteran biopharmaceutical and oncology leader brings more than three decades of experience across clinical development, regulatory, and operational execution SOUTH SAN FRANCISCO, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (("ALX Oncology, NASDAQ:ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, announced the appointment of Jeff Knight, M.P.H., as Chief Development and Operating Officer, effective April 13, 2026. "Jeff is a highly accomplished leader with deep expertise across clinical development and operations, and a strong track record of both advancing innovative thera

    4/13/26 8:30:00 AM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $AIRS
    $ALXO
    $AMC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Keefe Bruyette resumed coverage on Interactive Brokers with a new price target

    Keefe Bruyette resumed coverage of Interactive Brokers with a rating of Mkt Perform and set a new price target of $75.00

    4/8/26 8:36:42 AM ET
    $IBKR
    Investment Bankers/Brokers/Service
    Finance

    Wells Fargo initiated coverage on ALX Oncology with a new price target

    Wells Fargo initiated coverage of ALX Oncology with a rating of Overweight and set a new price target of $5.00

    3/19/26 8:25:33 AM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    UBS resumed coverage on ALX Oncology with a new price target

    UBS resumed coverage of ALX Oncology with a rating of Buy and set a new price target of $6.00

    3/6/26 8:38:03 AM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $AIRS
    $ALXO
    $AMC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Chernett Jorey bought $257,211 worth of shares (105,848 units at $2.43), increasing direct ownership by 2% to 6,592,059 units (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    3/16/26 6:43:51 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    Large owner Chernett Jorey bought $91,200 worth of shares (45,600 units at $2.00), increasing direct ownership by 0.72% to 6,398,211 units (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    3/9/26 8:40:24 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    Large owner Chernett Jorey bought $192,900 worth of shares (110,000 units at $1.75), increasing direct ownership by 2% to 6,352,611 units (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    3/4/26 6:58:41 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    $AAOI
    $AIRS
    $ALXO
    $AMC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chernett Jorey

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    4/15/26 9:35:08 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    SEC Form 4 filed by Murry Stefan J.

    4 - APPLIED OPTOELECTRONICS, INC. (0001158114) (Issuer)

    4/14/26 4:05:25 PM ET
    $AAOI
    Semiconductors
    Technology

    SEC Form 4 filed by George Gregory

    4 - MESOBLAST LTD (0001345099) (Issuer)

    4/13/26 7:19:39 AM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAOI
    $AIRS
    $ALXO
    $AMC
    Leadership Updates

    Live Leadership Updates

    View All

    ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer

    - Veteran biopharmaceutical and oncology leader brings more than three decades of experience across clinical development, regulatory, and operational execution SOUTH SAN FRANCISCO, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (("ALX Oncology, NASDAQ:ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, announced the appointment of Jeff Knight, M.P.H., as Chief Development and Operating Officer, effective April 13, 2026. "Jeff is a highly accomplished leader with deep expertise across clinical development and operations, and a strong track record of both advancing innovative thera

    4/13/26 8:30:00 AM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Premium In-Lobby Media Network Coming to 285 Movie Theatres Nationwide in a New Initiative from National CineMedia and Creative Realities

    National CineMedia (NASDAQ:NCMI) ("NCM"), the leading cinema advertising platform in the U.S. and a leading provider of digital signage, experiential solutions, and media network management, and Creative Realities, Inc. (NASDAQ:CREX) ("CRI"), a leading provider of digital media and AdTech solutions, today announced a new partnership to significantly expand and modernize AMC Theatres' (NYSE:AMC) in-lobby media footprint across 285 locations nationwide. This new initiative will turn the lobby at the participating theaters into a network of digital displays, including multiple 75-inch screens per location, that will deliver high-impact video, brand storytelling, and interactive experiences.

    4/13/26 8:00:00 AM ET
    $AMC
    $CNK
    $CREX
    Movies/Entertainment
    Consumer Discretionary
    EDP Services
    Technology

    It's 4/4, Time to Make a Wish: United & Make-A-Wish to Host 'Make More Wishes' Events Across Nation, Giving Wish Kids Behind-the-Scenes Access to Aviation

    Airline plans 2026 events on May 5 (5.5), June 6 (6.6), July 7 (7.7), August 8, (8.8), September 9 (9.9), October 10 (10.10), and November 11 (11.11)United honors 40 years of supporting Make-A-Wish as the airline celebrates its 100th anniversary with immersive experiences across hub airportsCHICAGO, April 4, 2026 /PRNewswire/ -- United Airlines and Make-A-Wish today announced the launch of "Make More Wishes," seven immersive events across the U.S. giving children fighting critical illnesses and their families behind-the-scenes access to all aspects of aviation. The immersive exp

    4/4/26 8:00:00 AM ET
    $UAL
    Air Freight/Delivery Services
    Consumer Discretionary

    $AAOI
    $AIRS
    $ALXO
    $AMC
    Financials

    Live finance-specific insights

    View All

    Applied Optoelectronics Announces Date of First Quarter 2026 Financial Results Conference Call

    SUGAR LAND, Texas, April 16, 2026 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (NASDAQ:AAOI) ("AOI"), a leading provider of advanced optical and HFC networking products that power AI, today announced that it will release financial results for its first quarter ended March 31, 2026, on Thursday, May 7, 2026. AOI will host a conference call and webcast for analysts and investors to discuss its first quarter 2026 financial results and outlook for its second quarter 2026 at 4:30 p.m. Eastern Time / 3:30 p.m. Central Time the same day. To participate in the call, please dial 844-890-1794 and ask to be joined to the AOI call. A live audio webcast of the conference call and supplemental fi

    4/16/26 4:10:00 PM ET
    $AAOI
    Semiconductors
    Technology

    Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products

    NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has acquired an exclusive worldwide license to a patented chimeric antigen receptor (CAR) technology platform for precision-enhanced augmentation of therapeutic mesenchymal lineage stromal cell (MSC) products. Mesoblast plans to incorporate the engineered CARs to further boost effectiveness of Mesoblast's products, with the goal of enhancing the target specificity and augmenting inherent properties of immunomodulation and tissue regeneration. Mesoblast's MSC technology platforms, including the first and on

    4/14/26 8:10:56 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    The Children's Place to Release Fourth Quarter and Year-End Fiscal 2025 Financial Results and Letter to Shareholders

    SECAUCUS, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- The Children's Place, Inc. (NASDAQ:PLCE), one of the only pure-play children's specialty retailers in North America with an omni-channel portfolio of brands and an industry-leading digital-first model, today announced that their fourth quarter and year-end fiscal 2025 financial results, and Turki S. AlRajhi's annual letter to shareholders, will be released on Friday, April 10, 2026 at approximately 4:30 p.m. Eastern Time, which can be accessed at https://corporate.childrensplace.com/. About The Children's Place The Children's Place is one of the only pure-play children's specialty retailers in North America with an omni-channel portfolio

    4/8/26 4:30:00 PM ET
    $PLCE
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $AAOI
    $AIRS
    $ALXO
    $AMC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mesoblast Limited

    SC 13G/A - MESOBLAST LTD (0001345099) (Subject)

    12/16/24 12:08:07 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Edible Garden AG Incorporated

    SC 13G/A - Edible Garden AG Inc (0001809750) (Subject)

    11/14/24 7:24:20 PM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    Amendment: SEC Form SC 13G/A filed by ALX Oncology Holdings Inc.

    SC 13G/A - ALX ONCOLOGY HOLDINGS INC (0001810182) (Subject)

    11/14/24 7:22:54 PM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care